Skip to main content
. Author manuscript; available in PMC: 2023 Jul 13.
Published in final edited form as: Eur J Cancer. 2021 Mar 19;148:215–229. doi: 10.1016/j.ejca.2021.01.050

Figure 3, Panels A and B.

Figure 3, Panels A and B.

PFS (panel A) and OS (Panel B) (from start of treatment) of patients on immunotherapy with STK11 mutations (N=21) versus those whose tumors are STK11 wild type (wt) (N=211).